Wednesday, Feb 19 2020 | Time 19:19 Hrs(IST)
image
  • Modi will visit B'desh in April for Bangabandhu centenary: FM
  • U-17 Football: India women beat Romania 1-0 in 2nd friendly match
  • SC seeks Centre reply on green transport in 4 weeks
  • India not rushing to sign trade deal with US during President Trump's visit
  • Haryana : Mother-son duo nabbed with 105 gm heroin
  • Sidhu directs civil surgeons to ensure compliance of environmental laws in hospitals
  • North East Sustainable Development Goals Conclave 2020 in Assam
  • Post-Brexit UK to have no place for low-skilled workers
  • Three-day Delhi Assembly session from Feb 24: Kejriwal
  • Water makes up 0 25 pc of Jupiter's atmosphere: NASA's Juno mission
  • Tomorrow’s cops shall have to be tech-savvy: MP CM
  • Australian Open champion Kenin loses opening match in Dubai
  • Bid to diffuse Shaheen Bagh blockade begins
  • India recommended as host for 2022 AFC Women’s Asian Cup
  • China revokes press cards of 3 WSJ journalists
World


China develops proto plasma for COVID-19 patients

China develops proto plasma for COVID-19 patients

Beijing, Feb 14 (UNI) According to the China National Biotech Group, the novel-coronavirus hit country has developed convulsive plasma to treat patients who are infected with novel coronaviruses (COVID-19).



The company said that they have collected plasma from some recovered patients to prepare therapeutic products including convalescent plasma and immune globulin, Xinhua reported.

After strict blood biosafety tests, virus inactivation and antiviral activity tests, they have successfully developed convalescent plasma for clinical treatment and have used it to treat critically ill patients.

The company has set up a team to use special equipment to collect plasma from recovered patients in Wuhan since Jan 20.

On February 8, three critically ill patients received confirmatory plasma treatment at a hospital in Wuhan's Jiangxia district. Currently, more than 10 critically ill patients have received treatment according to the company.

According to clinical results, 12 to 24 hours after the patients received treatment, they have shown improvement in clinical symptoms, with significantly reduced main inflammatory indexes and some major indices such as extensive improvement in blood oxygen saturation has happened.

UNI XC-GNK RHK1130

More News

Post-Brexit UK to have no place for low-skilled workers

19 Feb 2020 | 6:50 PM

London, Feb 19 (UNI) Britain will not grant visas to low-skilled workers under its newly unveiled immigration scheme after Brexit, UK Home Office said on Wednesday.

see more..

Water makes up 0 25 pc of Jupiter's atmosphere: NASA's Juno mission

19 Feb 2020 | 6:43 PM

Los Angeles, Feb 19 (UNI) According to NASA's Jet Propulsion Laboratory (JPL), Juno mission in its first result on the amount of water in Jupiter's atmosphere has found out that water makes up about 0.25 percent of the molecules in Jupiter's atmosphere -- almost three times that of the Sun.

see more..

China revokes press cards of 3 WSJ journalists

19 Feb 2020 | 6:23 PM

Beijing, Feb 19 (UNI) The press cards of three Wall Street Journal journalists who are based in Beijing will be revoked from Wednesday, China's Foreign Ministry spokesperson Geng Shuang said.

"The Chinese people do not welcome media that use racially discriminatory languages and maliciously slander and attack China," Xinhua quoted Geng during an online press briefing.

see more..
Fruit carrying citrus disease found in Australia

Fruit carrying citrus disease found in Australia

19 Feb 2020 | 5:48 PM

Canberra, Feb 19 (UNI) A killer disease capable of devastating Australia's citrus industry was found in the country, biosecurity officials have confirmed, Department of Agriculture, Water and Environment on Wednesday confirmed that officers recently seized fruit items entering Australia with citrus canker.

see more..
No trade deal during Trump India visit

No trade deal during Trump India visit

19 Feb 2020 | 4:42 PM

Washington, Feb 19 (UNI) India and the United States won't sign a trade deal during President Donald Trump's February 24-25 visit to New Delhi.

see more..
image